Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model

Transplant Immunology

Volumn 15, Issue 4, 2006, Pages 273-279

  Beiras Fernandez, Andres ^a,b   Chappell, Daniel ^a   Hammer, Claus ^a   Thein, Eckart ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anti thymocyte globulins; Inflammation; Ischemia; Reperfusion injury; Transplantation

Indexed keywords

POLYCLONAL ANTIBODY; RINGER LACTATE SOLUTION; TECELAC; THYMOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL STRUCTURE; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOLOGY; DRUG EFFECT; EXPERIMENTAL MODEL; FIBRIN FORMATION; HISTOLOGY; HUMAN; ISCHEMIA; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MACACA; MICROVASCULATURE; MONKEY; MUSCLE BIOPSY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIMATE; PRIORITY JOURNAL; REPERFUSION INJURY; TEMPERATURE; THROMBOCYTE ADHESION; TISSUE INJURY;

ANIMALS; ANTILYMPHOCYTE SERUM; BLOOD CELLS; BLOOD VESSELS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MACACA FASCICULARIS; MUSCLE, SKELETAL; RABBITS; REPERFUSION INJURY;

EID: 33646095991     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.02.003     Document Type: Article

References (31)

1. Massberg S., and Messmer K. The nature of ischemia-reperfusion injury. Transplant Proc 30 (1998) 4217-4223
2. Yokota N., Daniels F., Crosson J., and Rabb H. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation 74 6 (2002) 638-759
3. Thiel M., Immendorffer S., Chouker A., Groh J., Briegel J., Anthuber M., et al. Expression of adhesion molecules on circulating polymorphonuclear leukocytes during orthotopic Liver Transplantation. Hepatology 28 (1998) 1538-1550
4. Lefer A.M., Tsao P.S., Lefer D.J., et al. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 5 (1991) 2029-2034
5. Luscinskas F.W., Ma S., Nusrat A., et al. Leukocyte transendothelial migration: a junctional affaire. Semin Immunol 14 (2002) 105-113
6. Schneeberger H., Aydemir S., Illner W.D., et al. Non-specific primary ischemia/reperfusion injury in combination with secondary specific acute rejection-mediated injury of human kidney allografts contributes mainly to development of chronic transplant failure. Transplant Proc 29 (1997) 948-949
7. Menger M.D., Richter S., Yamauchi J., and Vollmar B. Role of microcirculation in hepatic ischemia/reperfusion injury. Hepatogastroenterology 46 Suppl. 2 (1999) 1452-1457
8. Michallet M.C., Preville X., Flacher M., Fournel S., Genestier L., and Revillard J.P. Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 75 5 (2003) 657-662
9. Bourdage J.S., and Hamlin M.D. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation 59 (1995) 1194-1200
10. Bonnefoy-Berard N., Vincent C., and Revillard J.P. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 51 (1991) 669-673
11. Charpentier B. A three arm study comparing immediate tacrolimus therapy with ATG induction therapy followed by either tacrolimus or cyclosporine in adult renal transplant recipients. Transplant Proc 34 (2002) 1625-1626
12. Brennan D.C., Flavin K., Lowell J.A., Howard T.K., Shenoy S., Burgess S., et al. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 67 7 (1999) 1011-1018 [Erratum in: transplantation 1999: 67(10):1386]
13. Morris R.E. New small molecule immunosuppressants for transplantation: review of essential concepts. J Heart Lung Transplant 12 (1993) S275-S286
14. Thein E., Sevilmis G., Muenzing S., Hammer C., and Messmer K. Evaluation of a system for the perfusion of isolated, rodent organs. Xenotransplantation 8 (2001) 94-99
15. Hammer C. Cytology in transplantation (1989), Verlag R.S. Schulz, Germany
16. Hsu S.M., and Raine L. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 29 (1981) 1349-1353
17. Koo D.D., Welsh K.I., Roake J.A., et al. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol 153 (1998) 557-566
18. Ojo A.O., Wolfe R.A., Held P.J., Port F.K., and Schmouder R.L. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 63 7 (1997) 968-974
19. St Peter S.D., Moss A.A., and Mulligan D.C. Effects of tacrolimus on ischemia-reperfusion injury. Liver Transpl 9 (2003) 105-116
20. Peralta C., Bulbena O., Bargallo R., Prats N., Gelpi E., and Rosello-Catafau J. Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation 70 (2000) 1761-1770
21. Schueler S., De Valeria P.A., Hatanaka M., Cameron D.E., Bando K., Zeebley M., et al. Successful twenty-four-hour lung preservation with donor core cooling and leukocyte depletion in an orthotopic double lung transplantation model. J Thorac Cardiovasc Surg 104 (1992) 73-82
22. Giannoukakis N., Thomson A., and Robbins P. Gene therapy in transplantation. Gene Ther 6 (1999) 1499-1511
23. Beiras-Fernandez A., Thein E., and Hammer C. Induction of immunosuppression with polyclonal anti-thymocyte globulins: an overview. Exp Clin Transpl 2 (2003) 79-85
24. Ito T., and Chiba S. Vascular responsiveness of simian digital artery to various vasoactive substances. J Invest Dermatol 86 (1986) 678-682
25. Bar T., Guldner F.H., and Wolff J.R. "Seamless" endothelial cells of blood capillaries. Cell Tissue Res 235 (1984) 99-106
26. Pascher A., Poehlein C., Storck M., Prestel R., Mueller-Hoecker J., White D.J., et al. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor. Transplantation 64 (1997) 384-391
27. Genestier L., Fournel S., Flacher M., Assossou O., Revillard J.P., and Bonnefoy-Berard N. Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 91 (1998) 2360-2368
28. Bonnefoy-Berard N., Fournel S., Genestier L., Flacher M., Quemeneur L., and Revillard J.P. In vitro functional properties of antithymocyte globulins: clues for new therapeutic applications?. Transplant Proc 30 (1998) 4015-4017
29. Hammer C., Klanke D., Lersch C., Dirschedl P., Kemkes B.M., Gokel M., et al. Cytoimmunologic monitoring (CIM) for differentiation between cardiac rejection and viral, bacterial, or fungal infection: its specificity and sensitivity. Transplant Proc 21 (1989) 3631-3633
30. Farooq M.M., Serra A., Newman P.J., Cambria R.A., Seabrook G.R., Towne J.B., et al. PECAM-1/IgG attenuates peroxynitrite-mediated extremity reperfusion injury. J Vasc Surg 34 (2001) 555-558
31. Goggins W.C., Pascual M.A., Powelson J.A., Magee C., Tolkoff-Rubin N., Farrell M.L., et al. A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 76 5 (2003) 798-802